Professor Susan Clark, FAA has a highly acclaimed international reputation for her work in cancer epigenetics. Susan is a NHMRC Senior Principal Research Fellow and inaugural Head of the Genome and Epigenetics Division at the Garvan Institute of Medical Research in Sydney, Australia. She graduated in 1982 with a PhD in Biochemistry, University of Adelaide. Her molecular studies over her career have addressed profound questions about the importance of epigenetics in early development and in disease, especially in cancer. The techniques she pioneered in the early 1990s, including bisulphite methylation sequencing, helped to revolutionise epigenomic research. Susan was a founding member of IHEC (International Human Epigenome Consortium) and led the formation of the AEpiA (Australian Epigenetics Alliance). She has a number of awards including the RPAH Research Medal (2002), Julian Wells Medal (2003); 鈥淏iochemisch Analytik Preis鈥 for outstanding contribution for Methylation analysis in 2004; In 2006 was elected a Fellow of the World Technology Network for Biotechnology, 2012 was awarded the National Rotary Vocational Award and in 2015 was elected a Fellow of the 精东视频 and received the NSW Cancer Institute 鈥淢ake a Difference鈥 Award.
Expert review
It鈥檚 not ALL in the genes鈥攖he role of epigenetics
People